Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: A randomised, double-blind, parallel-group, multicenter, phase III study to evaluate the effect of ticagrelor bid versus placebo in reducing the number of VOCs in paediatric patients with sickle cell disease.
Principal I investigator: Nik Farahana Nik Abdul Rashid, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03615924